Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MedCAC meets on Bayesian methods

This article was originally published in The Gray Sheet

Executive Summary

Medicare Evidence Development & Coverage Advisory Committee (MedCAC) will meet June 17 at CMS headquarters in Baltimore to discuss the application of Bayesian statistical analysis methods to the development of evidence for coverage decisions. The meeting will introduce Bayesian concepts, compare Bayesian and frequentist statistical approaches, and provide case examples of Bayesian meta-analyses. CMS recently released a 1technology assessment, titled "Use of Bayesian Techniques in Randomized Clinical Trials: A CMS Case Study." The document provides a basic tutorial on Bayesian statistics and a summary of published research on how Bayesian techniques "can modify inferences that affect policy-level decision making." FDA issued a 2draft guidance on Bayesian analysis in clinical trials in 2006
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT027550

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel